Annual EPS
-$4.06
+$0.66+13.98%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual earnings per share is -$4.06, with the most recent change of +$0.66 (+13.98%) on September 30, 2024.
- During the last 3 years, OTLK annual EPS has risen by +$2.94 (+42.00%).
- OTLK annual EPS is now at all-time high.
Performance
OTLK EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
$0.76
+$1.65+185.39%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly earnings per share is $0.76, with the most recent change of +$1.65 (+185.39%) on September 1, 2024.
- Over the past year, OTLK quarterly EPS has increased by +$1.56 (+195.00%).
- OTLK quarterly EPS is now at all-time high.
Performance
OTLK Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$8.94
+$1.75+16.37%
September 1, 2024
Summary
- As of February 7, 2025, OTLK TTM earnings per share is -$8.94, with the most recent change of +$1.75 (+16.37%) on September 1, 2024.
- Over the past year, OTLK TTM EPS has dropped by -$5.02 (-128.06%).
- OTLK TTM EPS is now -128.06% below its all-time high of -$3.92, reached on December 31, 2023.
Performance
OTLK TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
OTLK EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.0% | +195.0% | -128.1% |
| 3 y3 years | +42.0% | +147.5% | -24.2% |
| 5 y5 years | +89.8% | +110.6% | +71.0% |
OTLK EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.0% | at high | +109.5% | -128.1% | +21.6% |
| 5 y | 5-year | at high | +89.8% | at high | +106.1% | -128.1% | +79.3% |
| alltime | all time | at high | +99.3% | at high | +100.3% | -128.1% | +98.7% |
Outlook Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$4.06(-14.0%) | - | - |
| Sep 2024 | - | $0.76(-185.4%) | -$8.94(-16.4%) |
| Jun 2024 | - | -$0.89(-88.9%) | -$10.69(-6.3%) |
| Mar 2024 | - | -$8.01(+901.2%) | -$11.41(+191.1%) |
| Dec 2023 | - | -$0.80(-19.2%) | -$3.92(-16.9%) |
| Sep 2023 | -$4.72(-23.9%) | -$0.99(-38.5%) | -$4.72(-4.3%) |
| Jun 2023 | - | -$1.61(+209.6%) | -$4.93(+0.2%) |
| Mar 2023 | - | -$0.52(-67.5%) | -$4.92(-20.6%) |
| Dec 2022 | - | -$1.60(+33.3%) | -$6.20(0.0%) |
| Sep 2022 | -$6.20(-11.4%) | -$1.20(-25.0%) | -$6.20(-6.1%) |
| Jun 2022 | - | -$1.60(-11.1%) | -$6.60(+3.1%) |
| Mar 2022 | - | -$1.80(+12.5%) | -$6.40(0.0%) |
| Dec 2021 | - | -$1.60(0.0%) | -$6.40(-11.1%) |
| Sep 2021 | -$7.00(-47.8%) | -$1.60(+14.3%) | -$7.20(+0.6%) |
| Jun 2021 | - | -$1.40(-22.2%) | -$7.16(+12.6%) |
| Mar 2021 | - | -$1.80(-25.0%) | -$6.36(-45.9%) |
| Dec 2020 | - | -$2.40(+53.8%) | -$11.76(-46.0%) |
| Sep 2020 | -$13.40(-66.2%) | -$1.56(+160.0%) | -$21.76(-20.5%) |
| Jun 2020 | - | -$0.60(-91.7%) | -$27.37(-11.0%) |
| Mar 2020 | - | -$7.20(-41.9%) | -$30.77(-28.7%) |
| Dec 2019 | - | -$12.40(+72.9%) | -$43.17(-15.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | -$39.60(-79.7%) | -$7.17(+79.3%) | -$50.77(-29.1%) |
| Jun 2019 | - | -$4.00(-79.6%) | -$71.62(-34.7%) |
| Mar 2019 | - | -$19.60(-2.0%) | -$109.62(-23.5%) |
| Dec 2018 | - | -$20.00(-28.6%) | -$143.22(-39.5%) |
| Sep 2018 | -$194.80(-32.4%) | -$28.02(-33.3%) | -$236.82(-7.8%) |
| Jun 2018 | - | -$42.00(-21.1%) | -$256.80(+2.7%) |
| Mar 2018 | - | -$53.20(-53.2%) | -$250.00(-3.0%) |
| Dec 2017 | - | -$113.60(+136.7%) | -$257.60(-6.4%) |
| Sep 2017 | -$288.00(-51.0%) | -$48.00(+36.4%) | -$275.20(+3.6%) |
| Jun 2017 | - | -$35.20(-42.1%) | -$265.60(-45.4%) |
| Mar 2017 | - | -$60.80(-53.7%) | -$486.40(+6.3%) |
| Dec 2016 | - | -$131.20(+241.7%) | -$457.69(-11.3%) |
| Sep 2016 | -$587.20(+4.1%) | -$38.40(-85.0%) | -$516.00(-23.2%) |
| Jun 2016 | - | -$256.00(+697.9%) | -$672.11(+22.5%) |
| Mar 2016 | - | -$32.09(-83.1%) | -$548.44(-19.0%) |
| Dec 2015 | - | -$189.51(-2.6%) | -$676.91(+20.0%) |
| Sep 2015 | -$564.14(+141.4%) | -$194.51(+47.0%) | -$564.14(+52.6%) |
| Jun 2015 | - | -$132.33(-17.6%) | -$369.62(+55.8%) |
| Mar 2015 | - | -$160.56(+109.2%) | -$237.30(+209.2%) |
| Dec 2014 | - | -$76.74 | -$76.74 |
| Sep 2014 | -$233.70 | - | - |
FAQ
- What is Outlook Therapeutics annual earnings per share?
- What is the all time high annual EPS for Outlook Therapeutics?
- What is Outlook Therapeutics annual EPS year-on-year change?
- What is Outlook Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly EPS year-on-year change?
- What is Outlook Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Outlook Therapeutics?
- What is Outlook Therapeutics TTM EPS year-on-year change?
What is Outlook Therapeutics annual earnings per share?
The current annual EPS of OTLK is -$4.06
What is the all time high annual EPS for Outlook Therapeutics?
Outlook Therapeutics all-time high annual earnings per share is -$4.06
What is Outlook Therapeutics annual EPS year-on-year change?
Over the past year, OTLK annual earnings per share has changed by +$0.66 (+13.98%)
What is Outlook Therapeutics quarterly earnings per share?
The current quarterly EPS of OTLK is $0.76
What is the all time high quarterly EPS for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly earnings per share is $0.76
What is Outlook Therapeutics quarterly EPS year-on-year change?
Over the past year, OTLK quarterly earnings per share has changed by +$1.56 (+195.00%)
What is Outlook Therapeutics TTM earnings per share?
The current TTM EPS of OTLK is -$8.94
What is the all time high TTM EPS for Outlook Therapeutics?
Outlook Therapeutics all-time high TTM earnings per share is -$3.92
What is Outlook Therapeutics TTM EPS year-on-year change?
Over the past year, OTLK TTM earnings per share has changed by -$5.02 (-128.06%)